Training Programs

for the Individual

Learn to apply distinct Market Access Principles to any territory

A Tailored Approach to Each Unique Customer

ProFusion MAP is designed for the individual looking to better understand pressures in the healthcare marketplace and how they impact product access. Each MAP Program focuses on a different aspect of the marketplace in a two-step process: Building a Foundation and Live Discussion.

Designed for a Deeper Understanding

1

Building a Foundation

Immediately upon enrollment, gain access to select e-learning courses from ProFusion’s off-the-shelf course catalog. These courses have been chosen to provide a thorough foundation of knowledge on the topic of choice in preparation for the live discussion!

2

Live Discussion

Live discussions are hosted by a subject matter expert ready to pull-through and highlight key points from the assigned courses. This challenges the learner to think critically about marketplace trends impacting product access and how this relates to his or her own customers/business.​

What Participants are Saying

"Extremely valuable information not only for general knowledge but how to apply to my business planning and strategy."
MAP Program Participant
The Current and Future State of Healthcare

Applicable to Many Pharmaceutical Roles

Field Sales

Home Office

Reimbursement Managers

Account Executives

Hospital Sales

Key Account Managers

Begin Learning Today!

Purchase a MAP Program to immediately access select e-learning courses and enroll in a live discussion

Understanding the distribution of drug revenue amongst healthcare stakeholders

Revealing how key players competing within the healthcare industry impacts product access

Understanding the different mechanisms used by government payers to manage product access and patient care

Work Around Your Schedule

Many live discussion dates are available for each MAP Program. Enroll in the session that works for you after purchasing a Program.

March 2024
MonTueWedThuFriSatSun
26
27
28
29
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
6
7

Stay Updated on New MAP Programs and Dates

As the market access environment changes, relevant topics will be covered through new programs. Subscribe below to be the first to know about new MAP Program topics and added dates for existing Programs.





    Privacy Guaranteed — We will never share your info!

    Stay Updated on New MAP Programs and Dates

    As the market access environment changes, relevant topics will be covered through new programs. Subscribe below to be the first to know about new MAP Program topics and added dates for existing Programs.

    *required





      Privacy Guaranteed — We will never share your info!

      Manufacturers Restricting 340B Sales to Contract Pharmacies

      • Abbvie
      • Amgen
      • AstraZeneca
      • Boehringer Ingelheim
      • Eli Lilly
      • Merck
      • Novartis
      • Novo Nordisk
      • Sanofi
      • UCB
      • United Therapeutics
      • and more…